Tissue Engineering and Dental Implants Set to Boost 3D Printing in Healthcare to a $1.2 Billion Market by 2020

3D printing (3DP) or additive manufacturing (AM) is used to convert a 3D model into a three dimensional object and the material used for this purpose is called 3DP material. 3D printing has begun to flourish in various application areas in healthcare such as dental, medical, implants, drug manufacturing and so on.

3D printers in healthcare can use wide range of materials. On these lines, the 3D printing market has been segmented into donor cells, plastics, ceramics, and metals. Plastics have huge demand in 3D printing in healthcare industry due to their relatively low cost and their ease of manufacturing. Plastics/ Polymers were the most widely used materials for 3D printing in healthcare with estimated revenue of $189.9m in 2014. They are estimated to grow at a CAGR of 13.1% over the forecast period of 2015 – 2020. Ceramic materials were the second major shareholder in the global 3D printing in healthcare market while the utilization of donor cells for 3D printing in healthcare is estimated to grow at a highest CAGR of 28.8% during the forecast period.

The 3D printing technology has numerous applications in healthcare and can be segmented into implants & prosthetics, surgical guides, hearing aids, and tissue engineering. Implants and prosthetic limbs made of different types of metals and plastics are already employed and widely used in the healthcare industry. However, cost effective, customizable 3D printed prosthetic limbs have revolutionized the medical sector and will further fuel 3D printing medical applications. Dental laboratories have actively adopted 3D printed products in conducting surgeries of replacement and repairs. The demand for implants in this sector will rise further owing to increasing dental implant surgeries and operations. Dental Implants applications occupied largest share in global 3D printing in healthcare market with recorded revenue of $175.3m in 2014. Implants and Prosthetics applications were the second major shareholder while Tissue Engineering applications are estimated to grow at a highest CAGR of 26.2% over the forecast period. … (read more)

Source: MarketWatch.com